NAMPT and neoplasm: Successful implementation of the strategy to widen the therapeutic index of NAMPT inhibitors by co-administration with niacin, will depend on the ability to correctly detect functional NAPRT in tumor tissue and on the ability of normal tissue to be protected by niacin administration.